CA2116253A1 - Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant
- Google Patents
Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical CorpfiledCriticalOrtho Pharmaceutical Corp
Publication of CA2116253A1publicationCriticalpatent/CA2116253A1/fr
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
CA 21162531993-02-251994-02-23Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant
AbandonedCA2116253A1
(fr)
Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant
Vecteurs d'expression contenant des antisens inhibiteurs d'HIV et d'autres séquences nucléotidiques, vecteurs rétroviraux et rétrovirus recombinants les contenant
Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes
Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector
Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant